We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
VistaGen Therapeutics Inc | NASDAQ:VTGN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.50 | 4.19 | 4.56 | 0 | 09:16:18 |
NEVADA
|
001-37761
|
20-5093315
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification Number)
|
343 Allerton Ave.
South San Francisco, California 94090
|
(Address of principal executive offices)
|
|
VistaGen
Therapeutics, Inc.
|
|
|
|
|
Date:
December 8, 2017
|
By:
|
/s/ Shawn K. Singh
|
|
|
Shawn K.
Singh
Chief Executive
Officer
|
Exhibit
No.
|
|
Description
|
|
|
|
99.1
|
|
Press release
issued by VistaGen Therapeutics Inc., dated December 8,
2017.
|
1 Year VistaGen Therapeutics Chart |
1 Month VistaGen Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions